Detalhe da pesquisa
1.
Patients' priorities around drug-resistant tuberculosis treatment: A multi-national qualitative study from Mongolia, South Africa and Georgia.
Glob Public Health
; 18(1): 2234450, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37431789
2.
Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy.
BMJ Open
; 10(10): e036599, 2020 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33039989
3.
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial.
Lancet Respir Med
; 7(12): 1048-1058, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732485
4.
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
Lancet Respir Med
; 7(3): 249-259, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630778